Carastock.

Cara Therapeutics Inc’s trailing 12-month revenue is $27.2 million with a -410.9% profit margin. Year-over-year quarterly sales growth most recently was -70.0%. Analysts expect adjusted earnings to reach $-1.998 per share for the current fiscal year. Cara Therapeutics Inc does not currently pay a dividend.The stock of Cara Therapeutics Inc (CARA) has seen a -11.28% decrease in the past week, with a -16.90% drop in the past month, and a -60.67% decrease in the past quarter. The volatility ratio for the week is 10.49%, and the volatility levels for the past 30 days are at 10.66% for CARA.Trailing 12-Months. Asset Growth. -40.69%. Trailing 12-Months. Cara Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven ... CARA U.S.: Nasdaq Cara Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 28, 2023 6:54 a.m. EST Delayed quote $ 1.0000 0.07 7.37% Before Hours Volume: 1 Advanced...CARA Stock Analysis - Frequently Asked Questions Is Cara Operations a good dividend stock? Cara Operations (TSE:CARA) pays an annual dividend of C$0.41 per share and currently has a dividend yield of 1.54%.

CARA Stock Analysis - Frequently Asked Questions Is Cara Operations a good dividend stock? Cara Operations (TSE:CARA) pays an annual dividend of C$0.41 per share and currently has a dividend yield of 1.54%.Cara Therapeutics (CARA) Insider Trading Activity 2023. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. 15 best consumer discretionary stocks for the rest of 2023. All the trading advice you’ve ever received boils down to this (Ad) Closing prices for crude oil, gold and other commodities. Chick-fil-A Is Hiring an 'Entertainment Producer'.The drop in Cara Therapeutics stock was even more severe, plummeting 27% in after-hours trading. Investors had higher hopes for the biopharmaceutical company's rollout of injections of its Korsuva ...

Pruritus is defined as an unpleasant sensation that provokes the desire to scratch, but we know it’s much more than that. Chronic pruritus can be a devastating, disabling, and burdensome condition that significantly impairs quality of life. The millions of people who suffer from pruritus deserve relief.

Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA).This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Cara Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more. 1 minute.Cara Therapeutics Inc (CARA) stock is higher by 5.42% while the S&P 500 is lower by -0.08% as of 1:37 PM on Thursday, Apr 7. CARA has risen $0.69 from the previous closing price of $12.73 on volume of 256,141 shares. Over the past year the S&P 500 is higher by 9.75% while CARA is lower by -49.42%.Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%. CARA lost -$1.74 per share in the over the …

CARA Stock 12 Months Forecast. $14.10. (1230.19% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $14.10 with a high forecast of $25.00 and a low forecast of $3.50. The average price target represents a 1230.19% change from the last price of $1.06.

According to 6 analyst offering 12-month price targets in the last 3 months, Cara Therapeutics has an average price target of $18.17 with a high of $28.00 and a low of $4.00. Below is a summary of ...

26 thg 3, 2023 ... Tips Cara Stock Opname Efisien untuk Hasil yang Akurat · Hal yang Perlu Dipersiapkan Sebelum Membuat Stock Opname · Pelaksanaan Stock Opname.Aug 24, 2021 · CARA stock was up 2.8% as of Tuesday afternoon. On the date of publication, Nick Clarkson did not have (either directly or indirectly) any positions in the securities mentioned in this article. Cara Therapeutics, Inc.'s (NASDAQ:CARA) stock price has dropped 14% in the previous week, but insiders who sold US$111k in stock over the past year have had less luck. Given that the average selling price of US$10.28 is still lower than the current share price, insiders would probably have been better off keeping their shares.13 thg 11, 2023 ... CARA Stock Data. Industry Pharmaceutical Preparation Manufacturing. Sector Manufacturing. Website Link. Tags Health Technology, Biotechnology ...What's Happening with CARA Stock Today. Cara Therapeutics Inc (CARA) stock is higher by 2.07% while the S&P 500 is higher by 1.41% as of 3:38 PM on Wednesday, Mar 29. CARA is higher by $0.10 from the previous closing price of $4.94 on volume of 309,020 shares. Over the past year the S&P 500 is down -13.05% while CARA has fallen -58.65%.

Earnings date. 13 Nov 2023. Forward dividend & yield. N/A (N/A) Ex-dividend date. N/A. 1y target est. 10.29. Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.12 thg 3, 2018 ... Cara Operations, which also owns Swiss Chalet, saw sales grow 13.5 per cent in the fourth quarter to $774.9 million.Get cannabis news & stock picks delivered to your inbox. Enter your email below to join the official Technical420 newsletter. Email*.6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $15.86 in the next twelve months. This suggests a possible upside of 1,396.0% from the stock's current price.As of Friday, March 03, Cara Therapeutics Inc’s CARA share price has surged by 4.90%, which has investors questioning if this is right time to sell.

22 thg 3, 2023 ... Cara Therapeutics Inc Stock Price: Bottom Line. As of March 22, 2023, Cara Therapeutics Inc's stock price is $5.18, which is down 5.65% from its ...

Cara Therapeutics, Inc.'s (NASDAQ:CARA) stock price has dropped 14% in the previous week, but insiders who sold US$111k in stock over the past year have had less luck. Given that the average selling price of US$10.28 is still lower than the current share price, insiders would probably have been better off keeping their shares.In particular, the company currently has about $167 million in cash and marketable securities, and total liabilities are sitting around $19.5 million. Since the company suffered a loss of ~$88 ...A high-level overview of Cara Therapeutics, Inc. (CARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.585.00. +10.63%. 14.84M. View the real-time Cara Therapeutic (NASDAQ CARA) share price and assess historical data, charts, technical analysis and the share chat forum.Track Cara Therapeutics Inc (CARA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable …Cara Therapeutics, Inc. Common Stock (CARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.During the previous two years, 166 institutional investors and hedge funds held shares of Cara Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($30.96M), Disciplined Growth Investors Inc. MN ($15.91M), Chescapmanager LLC ($10.59M), BlackRock Inc. ($10.48M), Farallon Capital Management LLC ($9.80M), …Mar 31, 2023 · What's Happening With CARA Stock Today? Cara Therapeutics Inc (CARA) stock is trading at $5.05 as of 2:41 PM on Friday, Mar 31, an increase of $0.16, or 3.27% from the previous closing price of $4.89. The stock has traded between $4.90 and $5.06 so far today. What's Happening with CARA Stock Today Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%.Cara Therapeutics, Inc. Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties ...

218.25%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -8.64M. 47.45%. Get the latest Cara …

Nov 13, 2023 · Pruritus is defined as an unpleasant sensation that provokes the desire to scratch, but we know it’s much more than that. Chronic pruritus can be a devastating, disabling, and burdensome condition that significantly impairs quality of life. The millions of people who suffer from pruritus deserve relief. As of Friday, March 03, Cara Therapeutics Inc’s CARA share price has surged by 4.90%, which has investors questioning if this is right time to sell.Real-time Price Updates for Cara Therapeutics (CARA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreCara Therapeutics' current financial performance and market outlook do not paint an encouraging picture for investors. Find out why CARA stock is a Sell.Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.Cara Therapeutics' CEO is Chris Posner, appointed in Nov 2021, has a tenure of 5.25 years. total yearly compensation is $2.51M, comprised of 27.9% salary and 72.1% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $84.15K. The average tenure of the management team and the board of …This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Cara Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more. 1 minute.Cara Therapeutics Inc (CARA) stock is trading at $6.33 as of 3:12 PM on Thursday, Mar 9, a drop of -$0.09, or -1.33% from the previous closing price of $6.41. Volume today is more active than usual. So far 850,368 shares have traded compared to average volume of 621,904 shares. The stock has traded between $6.24 and $6.71 so …As of Friday, March 03, Cara Therapeutics Inc’s CARA share price has surged by 4.90%, which has investors questioning if this is right time to sell.

Find the latest Cara Therapeutics, Inc. (CARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Download stock pictures of Cara on Depositphotos ✓ Photo stock for commercial use - millions of high-quality, royalty-free photos & images.Cara Therapeutics Reports Second Quarter 2023 Financial Results. – 2Q23 total revenue of $6.9M including collaborative revenue of $5.4M from the Company’s share of profit of KORSUVA ® (difelikefalin) injection – – Demand for KORSUVA injection accelerating with 46% increase in vial orders quarter to quarter – – 2024 ESRD PPS ...Instagram:https://instagram. amd ai chipdiscretionary stocksgeni stock forecasturnj stock Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA). uga etfnextera energy stock dividend CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). best nft investments Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.Dec 1, 2023 · When is Cara Therapeutics's earnings date? Cara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 4th, 2024 based off last year's report dates. Learn more on CARA's earnings history.